Search details
1.
Pattern of disease progression during third-line or later chemotherapy with nivolumab associated with poor prognosis in advanced gastric cancer: a multicenter retrospective study in Japan.
Gastric Cancer
; 26(1): 132-144, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36316527
2.
aCGH Analysis of Predictive Biomarkers for Response to Bevacizumab plus Oxaliplatin- or Irinotecan-Based Chemotherapy in Patients with Metastatic Colorectal Cancer.
Oncologist
; 24(3): 327-337, 2019 03.
Article
in English
| MEDLINE | ID: mdl-30425180
3.
[Gastric Neuroendocrine Carcinoma(NEC)Treated with CDDP plus CPT-11 Chemotherapy].
Gan To Kagaku Ryoho
; 46(1): 65-69, 2019 Jan.
Article
in Japanese
| MEDLINE | ID: mdl-30765645
4.
First-line chemotherapy with S-1 alone or S-1 plus cisplatin for elderly patients with advanced gastric cancer: a multicenter propensity score matched study.
Gastric Cancer
; 21(5): 792-801, 2018 Sep.
Article
in English
| MEDLINE | ID: mdl-29353332
5.
Capecitabine and oxaliplatin combined with bevacizumab are feasible for treating selected Japanese patients at least 75 years of age with metastatic colorectal cancer.
BMC Cancer
; 15: 786, 2015 Oct 24.
Article
in English
| MEDLINE | ID: mdl-26497654
6.
Phase II feasibility study of preoperative chemotherapy with docetaxel, cisplatin, and fluorouracil for esophageal squamous cell carcinoma.
Cancer Sci
; 104(11): 1455-60, 2013 Nov.
Article
in English
| MEDLINE | ID: mdl-23991649
7.
Retrospective evaluation of the clinical necessity of external biliary drainage after pancreaticoduodenectomy.
Hepatogastroenterology
; 60(128): 2119-24, 2013.
Article
in English
| MEDLINE | ID: mdl-24088314
8.
First-line sunitinib plus FOLFIRI in Japanese patients with unresectable/metastatic colorectal cancer: a phase II study.
Cancer Sci
; 103(8): 1502-7, 2012 Aug.
Article
in English
| MEDLINE | ID: mdl-22537162
9.
Retrospective analysis of the international standard-dose FOLFIRI (plus bevacizumab) regimen in Japanese patients with unresectable advanced or recurrent colorectal carcinoma.
Int J Clin Oncol
; 16(5): 488-93, 2011 Oct.
Article
in English
| MEDLINE | ID: mdl-21416239
10.
[A clinicopathological study of 10 cases of primary small bowel adenocarcinoma].
Nihon Shokakibyo Gakkai Zasshi
; 108(3): 429-35, 2011 Mar.
Article
in Japanese
| MEDLINE | ID: mdl-21389664
11.
A multi-center retrospective analysis of survival benefits of chemotherapy for unresectable biliary tract cancer.
Jpn J Clin Oncol
; 37(11): 843-51, 2007 Nov.
Article
in English
| MEDLINE | ID: mdl-17942578
12.
A phase I study of hypofractionated radiotherapy followed by systemic chemotherapy with full-dose gemcitabine in patients with unresectable locally advanced pancreatic cancer.
Hepatogastroenterology
; 54(77): 1575-8, 2007.
Article
in English
| MEDLINE | ID: mdl-17708303
13.
Phase II study of radiotherapy employing proton beam for hepatocellular carcinoma.
J Clin Oncol
; 23(9): 1839-46, 2005 Mar 20.
Article
in English
| MEDLINE | ID: mdl-15774777
14.
Phase II trial of panitumumab with irinotecan as salvage therapy for patients with advanced or recurrent colorectal cancer (TOPIC study).
Oncol Lett
; 11(6): 4049-4054, 2016 Jun.
Article
in English
| MEDLINE | ID: mdl-27313739
15.
Relief of jaundice by external beam radiotherapy and intraluminal brachytherapy in patients with extrahepatic cholangiocarcinoma: results without stenting.
Hepatogastroenterology
; 51(58): 954-7, 2004.
Article
in English
| MEDLINE | ID: mdl-15239222
16.
Hepatic arterial infusion of 5-fluorouracil and extrabeam radiotherapy for liver metastases from pancreatic carcinoma.
Hepatogastroenterology
; 51(58): 1175-8, 2004.
Article
in English
| MEDLINE | ID: mdl-15239272
17.
Virtual pancreatoscopy of pancreatic cancer.
Hepatogastroenterology
; 50(50): 559-62, 2003.
Article
in English
| MEDLINE | ID: mdl-12749272
18.
A multicenter phase II trial of S-1 with concurrent radiation therapy for locally advanced pancreatic cancer.
Int J Radiat Oncol Biol Phys
; 85(1): 163-9, 2013 Jan 01.
Article
in English
| MEDLINE | ID: mdl-22677367
19.
Randomized, open-label, phase III study comparing irinotecan with paclitaxel in patients with advanced gastric cancer without severe peritoneal metastasis after failure of prior combination chemotherapy using fluoropyrimidine plus platinum: WJOG 4007 trial.
J Clin Oncol
; 31(35): 4438-44, 2013 Dec 10.
Article
in English
| MEDLINE | ID: mdl-24190112
20.
Therapeutic strategies for synchronous and multiple liver metastases from colorectal cancer.
Oncol Rev
; 6(1): e9, 2012 Mar 05.
Article
in English
| MEDLINE | ID: mdl-25992211